Recorded third quarter 2025 worldwide revenue of $384.0 million, GAAP fully diluted earnings per share of $0.41, adjusted fully diluted earnings ...
The slime coating frog bodies could hold the key to fighting infections, healings wounds and even curing cancer ...
Urteste S.A. launches European multicenter clinical study of the Panuri test Gdańsk, Poland – 6 November 2025 – Urteste S.A. (Warsaw Stock ...
More patients will receive faster, more convenient care from the comfort of their own homes, through the rollout of new digital technologies across ...
Bluetooth-connected power tools might seem unnecessary at first glance, but they actually offer real advantages.
Get key Q3 2025 insights on Vir Biotechnology’s accelerated hepatitis delta trial milestones, strong financials, and upcoming data catalysts.
Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.
Janux Therapeutics, Inc. (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor Activated T Cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback